Cell/Tissue Culture Supplies

Published by: Global Industry Analysts

Published: Aug. 1, 2006 - 424 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Cell/Tissue Culture Media, Sera and Reagents

II. EXECUTIVE SUMMARY

1. Market Dynamics

Outlook

Biopharmaceutical Drugs Fuel Cell Culture Market

Market Scenario

Industrial vs. Academic

Segmental Outlook

Regional Perspective

Market Structure

Leading Players

Table 1: Leading Players in US Cell/Tissue Culture Market (2003, 2004, & 2005E): Percentage Breakdown of Value Sales for Invitrogen, JRH Biosciences, Hyclone, Cambrex Bio Science Walkersville (Formerly BioWhittaker), Sigma-Aldrich, and Others (includes corresponding Graph/Chart)

2. Trends and Issues

Surging Demand for Cell Culture Products

Changing Trend Towards Serum-Free Media

Proteomics and Pharmacokinetics Drive Market Growth

CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture

Sluggish Fetal Bovine Serum Market

Cell Therapy Market Witnesses Increasing Consolidation Activity

Specialty Media Growing in Demand

Emerging Alternatives to Conventional Serum Supplemented Media

Growth of Defined Media

Regulations Prompt Change in Trends

Media Optimization

Other Trends

Manufacture-on-Demand: Gaining Momentum

Move Towards Contract Manufacturing

Factors Impacting Growth

Business Models Driving the Need for Contract Manufacturing

Trends in Contract Manufacturing

Target Sectors for Contract Manufacturers

3. End Use Analysis

End Use Applications

Cell Therapy

Growing by Leaps and Bounds

Cell Therapy Applications

Key Factors Affecting the Cell Therapy Market

Future Trends

Related Market Sectors

Progenitor Cell Therapy

Table 2: US Market for Progenitor Cell Therapy (2003 & 2004): Annual Sales in US$ Million for Blood Cells; Skin, Bone and Cartilage; and Others (includes corresponding Graph/Chart)

Table 3: US Market for Progenitor Cell Therapy (2003 & 2004): Percentage Breakdown by Value Sales for Blood Cells; Skin, Bone and Cartilage; and Others (includes corresponding Graph/Chart)

Stem Cell Therapy

Scope and Applications

Other Related Technologies

Somatic Cell Nuclear Transfer (SCNT)

Tissue Engineering

End Use Industries

4. Cell/Tissue Culture: Physiological Overview

Introduction

History

Plant Cell and Tissue Culture (PCTC)

Cell/Tissue Culture Media, Sera and Reagents

Classical Media

Specialty Media

Serum

Fetal Bovine Serum

Serum-Free Media

Cell Culture Reagents

Role of Tissue Culture in the Growth of Cell Types

Equipment

Storage and Preservation

Maintenance

Growth Pattern

Harvesting

Media and Growth Requirements

Physiological Parameters

Medium Requirements (Often Empirical)

Feeding

Safety Precautions

Methods of Tissue Culture

Preparation of Media

Growth and Morphology

Sub Culturing Adherent Cells

Trypsin-EDTA

EDTA Alone

Thawing Frozen Cells

Freezing Cells

Cell Culture Contamination - A Looming Problem

Classification

Major Cell Culture Contaminants

Chemical Contamination

Types and Sources of Potential Chemical Contaminants

Varied Sources of Chemical Contamination

Media and Components

Sera

Water

Storage Vessels

Fluorescent Lights

Endotoxins

Incubators

Biological Contamination

Varied Sources of Biological Contamination

Mycoplasmas

Airborne Particles and Aerosols

Cross Contamination by Other Cell Cultures

Consequences/Problems of Contamination

Controlling Cell Culture Contamination

Measures Aimed at Reducing Contamination Problems

5. Regulatory Environment

6. Product Introductions/Innovations

HyClone Introduces HyQ®CDM4MAb™ for Hybridoma Cell Lines

INTEGRA Biosciences Adds Alarm Interface to CELLROLL and CELLSPIN Systems

Nikon Launches New Imaging and Tracking Systems for Cell Culture

Genetix Develops Cell Dispenser

SAFC Biosciences Introduces LONGTMR3IGF-I for Industrial Cell Culture

Biocrystal Presents Opticell

TAP Unveils CompacT SelecT™

New Brunswick Scientific Augments New Products to Cell Culture Systems

Cell Culture Technologies Develops Fortified Production Media

HyClone Unveils New Microcarrier Product Line - HyQ®Spheres™

Celliance Brings Out LucraTone(TM) Peptones

Millipore Offers More Products for Cell Culture Assays

FibraStage™ Cell Culture System for Higher Yields

Acolyte to Incorporate AK Rapid® technology BacLite RapiTECT™ Range

Ventria Bioscience Unveiled Lacromin™ for Cell Culture Media

Vivascience Launches Vivadish

Celliance Corporation Unveils Hybri-CYTE(TM)

7. Recent Industry Activity

SAFC-Biosciences Forms to Support Sigma-Aldrich

Invitrogen and Cellartis to Co-develop hESC Reporter Lines

CELLCA and Rentschler Join Forces for Unique High-Level Expression System

ArcDia Partners with Chip-Man Technologies

Chugai Pharmaceutical Receives License for Cell Line from Cambrex Bio Science Walkersville, Inc

Chemicon Inks Distribution Agreement with CELLnTEC

Chemicon Signs an Agreement with ReNeuron

Chemicon to Market Stem Cell Products of ASCC

SCS and Chemicon Introduce ESGRO Complete™ Product Range

Serologicals Acquires Cytomyx Ltd

Millipore to Take Over Serologicals

CAT Opts SelectT™ for Higher Cell Culture Yields

SAFC to Market Cell Line Engineering of ProBioGen

Chemicon Licensed to Employ the RheoSwitch(R) System of RheoGene

SCS and Chemicon Sign an Agreement for ES Cell Media

Innovata Grants UCOE Gene Expression Technology to Celliance

Chemicon and Axordia Collaborate for New Antibody Markers

Genzyme Acquires Verigen AG

Chemicon Acquires Specialty Media

CalbaTech Pockets K-D Medical

Sigma- Aldrich Acquires JRH Biosciences

Invitrogen Acquires Dynal

Invitrogen Takes Over Biosource International

CellzDirect Takes Over HepatoTech

BD Acquires Atto Biosciences

Serologicals Corp Pockets AltaGen Biosciences

Serologicals Purchases Upstate Group

The Automation Partnership (TAP) Collaborates with MAIA SCIENTIFIC

Cambrex Bio Science signs agreement with QBM Cell Science

Serologicals Forms Celliance

JRH Biosciences Opens cGMP Facility

Vitrolife Bags Patent Approvals in the US and Europe

C3 Receives Clearance from Japanese Ministry of Health

Fisher Scientific Acquires Perbio Science

ICN Pharmaceuticals Divests Biomedicals Division

Boston Scientific Enters Into a Strategic Alliance with Osiris

Perbio Acquires FBS Supplier in Australia

BD Biosciences Collaborates with Harvard Institute of Proteomics

Serologicals in Global Distribution Agreement with Novo Nordisk

Invitrogen in Licensing Agreement for CHO Cell Lines

CMT Unveils New Facility at Pennsylvania

Serologicals Corp Acquires Intergen Co

Cambrex Acquires Bio Science Corp

Anthrogenesis Acquires Atlantic Stem Cells

Celmed Acquires NeuroGenomics and NeuroGeneration

HyClone and Kinetics Form HyNetics LLC

Aastrom Biosciences Enters Into a Co-Marketing Agreement With Bio Whittaker

Vitrolife Enters Into a Co-operation Agreement with Millenium

Perbio Acquires Pierce & Warriner

Sigma-Aldrich Acquires Ark Scientific

Sigma-Aldrich and Ajinomoto Enter Into Amino Acid Alliance

SeraCare Inc. and Grupo Grifols Enter Into Plasma Supply Agreement

Commonwealth Biotechnologies and Kemp Biotechnologies Sign Letter of Intent

Perbio Science Inks Agreement with Panymex International

Perbio’s HyClone Laboratories Inks Agreement with China Northwestern Minorities University

Perbio’s Cell Culture Division Signs Agreement with ConAgra

Serologicals Expands BSA Manufacturing Facility

Invitrogen Corporation Undergoes Restructuring

Serologicals Divests Seramed to Aventis

SeraCare Inc. Divests Consolidated Technologies

8. Focus on Select Major Players

AMRESCO Inc (USA)

Analytical Biological Services (USA)

BD Biosciences (USA)

Cambrex Bio Science Walkersville, Inc (USA)

Cell Culture Technologies (Switzerland)

Cell Essentials (USA)

MP Biomedicals (USA)

Invitrogen (USA)

Irvine Scientific (USA)

JRH Biosciences (USA)

Kemp Biotechnologies (USA)

Mediatech Inc. (USA)

Medi-Cult (Denmark)

PerBio Science (Sweden)

PromoCell (Germany)

Sera Laboratories International (UK)

Serologicals Corp (USA)

Sigma-Aldrich (USA)

SAFC Biosciences (USA)

USB Corp (USA)

Vitrolife AB (Sweden)

Wisent Inc. (Canada)

9. Global Market Perspective

Table 4: World Recent Past, Current & Future Market Analysis for Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 5: World 10-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 6: World Recent Past, Current & Future Market Analysis for Media Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 7: World 10-Year Perspective for Media Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 8: World Recent Past, Current & Future Market Analysis for Sera Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 9: World 10-Year Perspective for Sera Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 10: World Recent Past, Current & Future Market Analysis for Reagent Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 11: World 10-Year Perspective for Reagent Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Biotech Industry in the US

Cell & Tissue Culture Market

A Brief Insight

Grade Definitions

Market Trends

Trend Towards Serum-Free Media

Table 12: US Market for Cell Culture (2004): Percentage Breakdown of Value Sales for Media, Sera and Reagents by End Use Application - Industrial and Academic (includes corresponding Graph/Chart)

Table 13: US Market for Cell Culture (2004): Percentage Breakdown of Value Sales by Industrial and Academic End Use Application for Liquid Media, Powdered Media, Fetal Bovine Serum, Serum-free and Protein-free Media, Growth Factors, Other Sera, Supplements, Antibiotics, and Other Products (includes corresponding Graph/Chart)

Liquid and Powdered Media Account for Major Share

Fetal Bovine Serum - Uses on a Decline

Table 14: Leading Producers of Fetal Bovine Serum in the US (2004): Percentage Breakdown of Value Sales for Life Technologies, Hyclone, and Others (includes corresponding Graph/Chart)

Bovine Serum Industry: Highly Unpredictable

Suppliers Searching for New Areas

Sustained Rise of Serum-Free and Protein- Free Media

Rise in Cell Culture Equipment Demand Leads to Innovation

End Use Analysis

Table 15: US Market for Cell and Tissue Culture (2004): Percentage Share by Research Application for Cellular Research, Protein Expression, Protein Production, Cell Therapy, and Cell Transplantation (includes corresponding Graph/Chart)

Table 16: US Market for Cell Culture Reagents (2004): Percentage Breakdown of Value Sales for End Use Applications- Academic, Industrial, and Non-Academic (includes corresponding Graph/Chart)

Table 17: Leading Players in US Cell/Tissue Culture Market (2003, 2004, & 2005E):Percentage Breakdown of Value Sales for Invitrogen, JRH Biosciences, Hyclone, Cambrex Bio Science Walkersville (Formerly BioWhittaker), Sigma-Aldrich, and Others (includes corresponding Graph/Chart)

Factors Influencing the Market for Tissue and Cell Culture Media

Regulatory Controls

Guidelines Governing Use of Cell/Tissue Culture Reagents

MSDS and Hazardous Information

Toxic Substances Control Act

Key Players

AMRESCO Inc

Analytical Biological Services

BD Biosciences

Cell Applications Inc

Cell Essentials

Cambrex Bio Science Walkersville, Inc

MP Biomedicals (USA)

Invitrogen

Irvine Scientific

Mediatech Inc

Serologicals Corp

Sigma-Aldrich

SAFC Biosciences

USB Corp

Product Introductions/Innovations

Strategic Developments

B. Market Analytics

Table 18: US Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 19: US 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

2. Canada

A. Market Analysis

Overview

Biotechnology Industry

Wisent Inc - A Key Player

Strategic Developments

B. Market Analytics

Table 20: Canadian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 21: Canadian 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

3. Japan

A. Market Analysis

Cell and Tissue Culture Market

Biotechnology Industry in Japan

Strategic Development

B. Market Analytics

Table 22: Japanese Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 23: Japanese 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4. Europe

A. Market Analysis

Biotech and Life-Science Research

Market Overview

B. Market Analytics

Table 24: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region - France, Germany, UK, Italy & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 25: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 26: European 10-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy & Rest of Europe Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 27: European 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4a. France

A. Market Analysis

B. Market Analytics

Table 28: French Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 29: French 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4b. Germany

A. Market Analysis

Biotech Research Scenario

Table 30: German Biotech Market: Percentage Share in 2004 by Application Area for Environment, Human Health Care, Chemical industry, Food, Agriculture, Energy, and Others (includes corresponding Graph/Chart)

PromoCell - A Key Player

Strategic Developments

B. Market Analytics

Table 31: German Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 32: German 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4c. The United Kingdom

A. Market Analysis

Cell and Tissue Culture Market

Biotechnology Industry - A Brief Insight

Research Entities

Commercial Activities

Outlook

Regulatory Issues

HFE Act Guidelines

The Ethical Issues

Sera Laboratories International- A Key Player

Strategic Corporate Developments

Product Launches

B. Market Analytics

Table 33: UK Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 34: UK 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4d. Italy

A. Market Analysis

B. Market Analytics

Table 35: Italian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 36: Italian 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4e. Rest of Europe

A. Market Analysis

Cell and Tissue Culture Market

Scenario in other European Countries

Key Players

Cell Culture Technologies (Switzerland)

Medi-Cult (Denmark)

PerBio Science (Sweden)

Vitrolife AB (Sweden)

Strategic Developments

B. Market Analytics

Table 37: Rest of Europe Market for Cell/Tissue Culture Supplies - Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 38: Rest of Europe 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

5. Asia-Pacific

A. Market Analysis

Overview

India

China

Taiwan

Australia

Strategic Developments

B. Market Analytics

Table 39: Asia-Pacific Market for Cell/Tissue Culture Supplies - Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 40: Asia-Pacific 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

6. Latin America

A. Market Analysis

Cell and Tissue Culture Market

Brazilian Biotech Industry

B. Market Analytics

Table 41: Latin American Market for Cell/Tissue Culture Supplies - Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 42: Latin American 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

IV. COMPETITION

1. Aastrom Biosciences, Inc. (USA)

Table 43: Annual Sales Analysis: 2004-2006(In US$ million)

2. ABgene (UK)

3. Acolyte Biomedica Limited (UK)

4. Advanced Biotechnologies, Inc. (USA)

5. American Type Culture Collection (USA)

6. Amphioxus Cell Technologies, Inc. (USA)

7. Amresco, Inc. (USA)

8. Analytical Biological Services, Inc. (USA)

9. Australian Stem Cell Centre (ASCC) (Australia)

10. Barloworld Scientific Ltd. (UK)

Techne, Inc. (USA)

R&D Systems, Inc. (USA)

11. Barnstead International (USA)

12. Becton Dickinson and Company (USA)

Table 44: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 45: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

Table 46: Annual Sales Analysis: 2004-2005(In US$ million)

BD Biosciences (USA)

13. Bellco Glass, Inc. (USA)

14. Biochrom AG (Germany)

15. Biocientifica SA (Argentina)

16. BioCrystal Limited (USA)

17. Biodesign International (USA)

18. Biohit PLC (Finland)

Table 47: Annual Sales Analysis: 2004-2005(In € million)

Table 48: Annual Sales Analysis by Segment: 2004-2005 (In € million)

19. Biological Industries (Israel)

20. Biomedical Technologies, Inc. (USA)

21. Bio-Rad Laboratories, Inc. (USA)

Table 49: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 50: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

Table 51: Annual Sales Analysis: 2004-2005(In US$ million)

Table 52: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 53: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 54: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

22. Biotage LLC (USA)

23. Biowest (France)

24. Boston Scientific Corporation (USA)

Table 55: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ billion)

Table 56: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ billion)

Table 57: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In US$ billion)

Table 58: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ billion)

Table 59: Annual Sales Analysis: 2004-2005 (In US$ billion)

Table 60: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ billion)

Table 61: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion)

Table 62: Annual Sales Analysis by Quarter: 2004-2005 (In US$ billion)

25. Brandtech Scientific, Inc. (USA)

26. Calbatech, Inc. (USA)

Table 63: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 64: Annual Sales Analysis: 2004-2005 (In US$ million)

27. Cambrex Bio Science Walkersville (USA)

28. Cell Applications, Inc. (USA)

29. Cell Culture Technologies (Switzerland)

30. Cell Essentials, Inc. (USA)

31. Cell Sciences, Inc. (USA)

32. Cellartis AB (Sweden)

33. Cellca GmbH (Germany)

34. Cellntec Advanced Cell Systems AG (Switzerland)

35. Cellontech Co., Ltd. (Korea)

36. Cellzdirect, Inc. (USA)

37. Centerchem, Inc. (USA)

38. Chemicon International, Inc. (USA)

39. Chugai Pharmaceutical Co., Ltd. (Japan)

Table 65: First Quarter Sales Analysis: 2005-2006 (In ¥ million)

Table 66: Annual Sales Analysis: 2004-2005 (In ¥ million)

40. Clinical Cell Culture Ltd. (UK)

41. Commonwealth Biotechnologies, Inc. (USA)

Table 67: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ thousands)

Table 68: Half Yearly Sales Analysis by Operations: 2005-2006 (H1) (In US$ thousands)

42. Conception Technologies (USA)

43. Corning, Inc. (USA)

Table 69: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 70: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 71: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 72: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 73: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 74: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

44. Coy Laboratory Products, Inc. (USA)

45. CSL Biosciences (Australia)

Table 75: Annual Sales Analysis: 2005-2006 (In A$ million)

Table 76: Annual Sales Analysis by Geographic Region: 2005-2006 (In A$ million)

46. Digene Corporation (USA)

Table 77: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended March) (In US$ million)

Table 78: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

47. Don Whitley Scientific Ltd. (UK)

48. Drummond Scientific Co. (USA)

49. Essen Instruments (USA)

50. Fertipro NV (Belgium)

51. Gemini Bio-Products (USA)

52. Genetix Ltd. (UK)

Table 79: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million)

Table 80: Annual Sales Analysis: 2004-2005 (In £ million)

53. Genzyme Corporation (USA)

Table 81: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 82: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 83: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

Table 84: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 85: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 86: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 87: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion)

54. Globepharm Ltd. (UK)

55. Greiner Bio-One GmbH (Germany)

56. GroPep Limited (Australia)

Table 88: Annual Sales Analysis: 2005-2006 (In A$ million)

Table 89: Annual Sales Analysis by Business Segment: 2005-2006 (In A$ million)

57. Grupo Grifols (Spain)

58. Harvard Bioscience, Inc. (USA)

Table 90: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 91: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 92: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 93: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 94: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

59. Imgenex Corporation (USA)

60. Integra Biosciences AG (Switzerland)

61. Invitrogen Corporation (USA)

Table 95: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 96: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 97: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 98: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 99: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Biofluids/Invitrogen-Gibco (USA)

Bioreliance Corporation (USA)

Biosource International, Inc. (USA)

Biosource Europe SA (Belgium)

62. Irvine Scientific, Inc. (USA)

63. Kemp Biotechnologies (USA)

64. Kimble Kontes Glass, Inc. (USA)

65. Leica Microsystems, Inc. (USA)

66. Mandel Scientific Company, Inc. (Canada)

67. Mediatech, Inc. (USA)

68. Medi-Cult A/S (Denmark)

69. Midwest Scientific (USA)

70. Millenium Biologix Corporation (USA)

Table 100: First Quarter Sales Analysis: 2006-2007 (In US$ million)

Table 101: First Quarter Sales Analysis by Segment: 2006-2007 (In US$ million)

71. Millipore Corporation (USA)

Table 102: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 103: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

Table 104: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million)

Table 105: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 106: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 107: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 108: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Celliance Corporation/Millipore's Bioprocess Division (USA)

72. Minerva Biolabs GmbH (Germany)

73. MP Biomedicals (USA)

74. Nalge Nunc International, Inc. (USA)

75. New Brunswick Scientific Co., Inc. (USA)

Table 109: First Quarter Sales Analysis: 2005-2006 (In US$ million)

Table 110: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 111: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 112: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

76. Nikon Corporation (Japan)

Table 113: Annual Sales Analysis: 2004-2006 (In ¥ million)

Table 114: Annual Sales Analysis by Segment: 2005-2006 (In ¥ million)

Table 115: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ million)

Table 116: Annual Sales Analysis by Segment: 2004-2005 (In ¥ million)

Table 117: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ million)

77. Osiris Therapeutics, Inc. (USA)

Table 118: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

78. Pall Corporation (USA)

Table 119: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 120: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 121: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Table 122: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 123: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

79. Para Scientific Company (USA)

80. ProBioGen AG (Germany)

81. Promocell GmbH (Germany)

82. Quality Biological, Inc. (USA)

83. ReNeuron Ltd. (UK)

84. Rentschler Biotechnologie (Germany)

85. Research Organics, Inc. (USA)

86. Roche Molecular Biochemicals (USA)

87. Sartorius AG (Germany)

Table 124: Annual Sales Analysis: 2004-2005 (In € million)

Sartorius BBI Systems GmbH (Germany)

Sartorius BBI Systems, Inc. (USA)

Sartorius Vivascience GmbH (Germany)

88. SC Proven (UK)

89. Scientific Industries, Inc. (USA)

Table 125: Annual Sales Analysis: 2005-2006 (In US$ thousands)

90. Sentigen Holding Corporation (USA)

Table 126: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 127: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 128: Half Yearly Sales Analysis by

Business Operation: 2005-2006 (H1) (In US$ million)

Table 129: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 130: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 131: Annual Sales Analysis by Business

Operation: 2004-2005 (In US$ million)

Sentigen Biosciences (USA)

Cell And Molecular Technologies, Inc. (USA)

91. Sera Laboratories International Ltd. (UK)

92. Serotec Ltd. (UK)

93. Sigma-Aldrich Corporation (USA)

Table 132: First Quarter Sales Analysis: 2005-2006 (In US$ million)

Table 133: First Quarter Sales Analysis by

Segment: 2005-2006 (In US$ million)

Table 134: First Quarter Sales Analysis by

Geographic Region: 2005-2006 (In US$ million)

Table 135: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 136: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 137: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 138: Annual Sales Analysis by

Geographic Region: 2004-2005 (In US$ million)

SAFC Biosciences (USA)

Sigma-Aldrich Co., Ltd. (UK)

94. Spectrocell (USA)

95. Spectrum Laboratory Products Inc. (USA)

96. Stem Cell Sciences PLC (UK)

Table 139: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million)

97. Stratagene, Inc. (USA)

Table 140: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 141: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 142: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 143: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 144: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 145: Annual Sales Analysis by

Geographic Region: 2004-2005 (In US$ million)

98. Surmodics, Inc. (USA)

Table 146: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 147: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million)

Table 148: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

Table 149: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 150: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 151: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

99. The Automation Partnership (TAP) (UK)

100. The Binding Site, Inc. (USA)

101. Thermo Fisher Scientific, Inc. (USA)

Table 152: Annual Sales Analysis: 2004-2005 (In US$ million)

Cole-Parmer Instrument Co. (USA)

PerBio Science AB (Sweden)

Hyclone Laboratories, Inc. (USA)

102. Thomas Scientific (USA)

103. USA Scientific, Inc. (USA)

104. USB Corporation (USA)

Table 153: Annual Sales Analysis: 2004-2005 (In US$ million)

105. Ventria Bioscience (USA)

106. Vitrolife AB (Sweden)

107. Wave Biotech LLC (USA)

108. Whatman PLC (UK)

Table 154: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million)

Table 155: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In £ million)

Table 156: Half Yearly Sales Analysis by

Geographic Region: 2005-2006 (H1) (In £ million)

Table 157: Annual Sales Analysis: 2004-2005 (In £ million)

Table 158: Annual Sales Analysis by Segment: 2004-2005 (In £ million)

Table 159: Annual Sales Analysis by Geographic Region: 2004-2005 (In £ million)

109. Wheaton Science Products (USA)

110. Wisent, Inc. (Canada)

Abstract

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.